July 2024: media monitoring and press review

Category FIVAPE Press review

FIVAPE's media watch on vaping in France and around the world: July 2024

This logo points out a quote from FIVAPE. Follow us on our social networks Linkedin, Facebook and Xor by subscribing to our newsletters and press releases.

07/30/24 | BFMTV

Parallel markets, but also and above all young people who smoke much less. Where is the "gateway effect", the pretext for systematically denigrating vaping?

Tobacco: 400 million euros in taxes will be lost to the State in 2024 due to the drop in the number of cigarettes sold in France

07/25/24 | CEBM

The Cochrane systematic review provides a highly reliable overview of the scientific literature on vaping as a smoking cessation aid, and is updated continuously (last update 1/7/24).

Electronic Cigarettes for Smoking Cessation: Cochrane Living Systematic Review

07/20/24 | VAPINGPOST

Presentation of the actions of FIVAPE, SOVAPE and AIDUCE. Let's make the public authorities understand the unbridgeable red line between the tobacco industry and independent vapers, at the forefront of the fight against smoking.

Defending vaping in France: major actions by associations

07/18/24 | THE COUNTERFACTUAL

Michael Anthony Hamilton Russell, psychiatrist and public health scientist, began his research into tobacco and nicotine in the 1970s. He is considered a visionary in the field of harm reduction.

The genius of Michael Russell - more right than ever

07/17/24 | VAPINGPOST

The next TPD will be crucial for vape, for users, for our businesses. FIVAPE, which represents professionals independent of the tobacco industry, will be relentless in its defense of the most effective and popular smoking cessation aid.

The composition of the European Commission for the next PDT is now known

07/16/24 | VAPINGPOST

Opinion column by Jean Moiroud, President of FIVAPE. Citizen user associations and vape professionals, independent of the tobacco industry, stand shoulder to shoulder to defend the most popular aid for quitting smoking. Thank you for your support!

Vape thanks you

07/15/24 | VAPINGPOST

Excellent, comprehensive article on the manufacture and safety of eliquids. The French vape industry, independent of the tobacco industry, reveals its know-how and commitments in complete transparency.

How do liquidators protect themselves from risk?

11/07/24 | ADDICT'AIDE

Varenicline is no longer available as a prescription drug, having been withdrawn from the market by its manufacturer. As for vape, it is freely available, with expert advice, in over 3,500 specialist stores.

Smoking cessation: vape as effective as varenicline

3/07/24 | LA LIBRE

A plea for harm reduction. Frank Baeyens, Professor at the Faculty of Psychology and Educational Sciences (KU Leuven), and Konstantinos Farsalinos, Associate Researcher at the University of Patras and the University of Western Attica (Greece).

Time to promote tobacco risk reduction

4/07/24 | VAPINGPOST

In Australia, the government is having to back down in the face of rules that are far too strict (prescriptions, sale in pharmacies) and that hamper access to vaping for smokers.

Vaping in Australia no longer requires a prescription

3/07/24 | VAPINGPOST

Scientists are questioning the reliability of methods that count young people who vapotage, in particular distinguishing between experimentation and regular consumption.

Do so many young people smoke? Probably not, according to these scientists

3/07/24 | FÉDÉRATION ADDICTION

SAVE THE DATE: October 11, 2024. Fédération Addiction is organizing a webinar on "Tobacco and precariousness" for healthcare professionals and social workers.

Webinar on tobacco and precariousness